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Abstract
Background—Early palliative/supportive care (PSC) consultation and advance care planning
(ACP) improve outcomes for patients with incurable cancer. However, PSC is underutilized in the
United States.
Objective—To examine philosophical differences among PSC, radiation oncology (RO), and
medical oncology (MO) physicians in order to understand barriers to early PSC referral.
Design—An electronic survey collected views of a nationwide cohort of health-care
professionals regarding ACP and end-of-life care.
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Setting/Participants/Measurements—A subgroup analysis compared the responses from all
51 PSC, 178 RO, and 81 MO physician participants (12% response rate), using Pearson χ2 and
Mann-Whitney U tests for categorical and ordinal data, respectively.
Results—More statistically significant differences were observed between RO-PSC (12
questions) and MO-PSC (12 questions) than RO-MO (4 questions). Both RO and MO were more
likely than PSC physicians to believe doctors adequately care for emotional (P < .001) and
physical (P < .001) needs of patients with an incurable illness. Both RO and MO were also less
likely to believe that PSC physicians were helpful at addressing these needs (P = .002 and <.001,
respectively) or that patients’ awareness of their life expectancy leads to better medical (P = .007
and .002, respectively) and personal (P = .001 for each) decisions. Palliative/supportive care
physicians felt that doctors are generally less successful at explaining/clarifying advanced lifesustaining treatments than RO (P < .001) or MO (P = .004). MO favored later initiation of ACP
than either RO (P = .006) or PSC physicians (P = .004).
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Conclusions—Differences in perception of appropriate end-of-life care exist between
oncologists and PSC physicians, suggesting a need for improved education and communication
between these groups.
Keywords
palliative care; end-of-life care; advance care planning; cancer; radiation oncology; medical
oncology

Purpose/Objectives
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Palliative/supportive care (PSC) is a medical discipline that focuses on maximizing quality
of life for patients with an incurable illness and limited life expectancy. Palliative/supportive
care physicians emphasize control of physical and mental symptoms such as pain, anxiety,
and depression and help patients engage in advance care planning (ACP) in order to ensure
that when their health status changes the care received corresponds with their goals and
wishes. Unfortunately, the US health-care system is notable for delivering more aggressive
treatments than most patients would prefer at the end of life,1–7 but better utilization of PSC
has the potential to ameliorate this problem. Seven randomized trials have demonstrated that
early PSC consultation improves outcomes for patient with incurable cancer, leading the
American Society of Clinical Oncology (ASCO) to recommend integration of PSC into
standard oncology care for all patients with distant metastases and late-stage disease and/or
when the prognosis is less than 24 months.8,9
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Yet, despite this strong evidence and consensus guidelines supporting its use, PSC services
remain underutilized at many US institutions.10–14 A variety of reasons may be causing this
problem. There is a shortage of PSC physicians to care for patients with cancer in the United
States,15 which may impact access to care in more rural community settings. However, at
most academic medical centers where resources are generally less scarce, the timing of PSC
involvement for a patient with advanced cancer may be largely determined by the
oncologist(s) who decide when to place the referral. As such, it is plausible that delayed PSC
referral may hinge less so on evidence and more so on trust that the PSC physician will
support the patient and the oncology team and not simply usher the patient toward hospice
or away from cancer-directed therapies “prematurely.” There also may be knowledge gaps
between oncology and PSC physicians, as Accreditation Council for Graduate Medical
Education (ACGME) requirements do not mandate any formal PSC training for oncology
residents/ fellows, nor oncology training for PSC fellows,16 which may lead to each party
lacking a basic understanding of each other’s specialty, perspective on the effects of
treatments, or how each views their role in the multidisciplinary team. As has been
demonstrated in other aspects of oncology, differences in philosophy, knowledge, and trust
can significantly impact referral patterns, which in turn impacts the delivery of effective
patient care.17–20
Previous studies have examined the views of oncologists and other health-care professionals
with regard to palliative care21–28; however, none have directly compared the views of
different types of oncologists and PSC physicians to each other in order to better understand
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differences in philosophy that may exist. Here, we present an analysis comparing the views
of radiation oncology (RO), medical oncology (MO), and PSC participants from an
electronic survey of health-care professionals that assessed their views on ACP and end-oflife care in the United States.

Methods

Author Manuscript

This study made use of a data set from a 28-item electronic survey that was initially sent in
2013 to health-care professionals in the United States who were thought to have contact with
patients with advanced stage cancer.29 A total of 5595 radiation oncologists, medical
oncologists, surgical oncologists, nurses, and palliative care physicians whose contact
information was available through the American Society for Radiation Oncology (http://
www.astro.org) and ASCO (http://www.asco.org) online databases were surveyed, and 645
responses were received (12% response rate, 3.6% margin of error at 95% confidence
interval). For the current subgroup analysis, all physician participants in the fields of
radiation oncology (n = 178), medical oncology (n = 81), and palliative care (n = 51) were
compared.
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The structure of the survey has been described previously,29 but briefly, the questions can be
divided into 3 domains, assessing participants’ views on (1) how well the US health-care
system addresses ACP and end-of-life care among patients, (2) the optimal logistics for
ACP, and (3) the type of end-of-life care participants would want for themselves. Question
formats included multiple choice and Likert-type scales (from 1 to 5, with 1 being the worst,
lowest, or least likely option and 5 being the best, highest, or most likely option, depending
on the question). All of the survey questions and answers options can be found in
Supplementary Tables 1, 2, and 3. Descriptive statistics were reported as frequency counts,
percentages, medians (with interquartile ranges), and means (with standard deviation) for
each of the 3 subspecialties. The χ2 test was used to compare each subgroup for questions
with categorical data, whereas the Mann-Whitney U test was used to compare each subgroup
for questions with ordinal data. Finally, ordinal regression was used to control for gender
and years of experience as covariates. A P value less than .05 was considered statistically
significant. Data analysis was performed using IBM SPSS Statistics version 21.

Results
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The demographics of the physician participants are shown in Table 1. Palliative/supportive
care participants had significantly fewer years of experience and were more likely to be
female compared to RO and MO (P < .01). Overall, a greater number of questions with
statistically significant differences in responses were observed between RO and PSC
physicians (12 questions) and MO and PSC physicians (12 questions) than between RO and
MO (4 questions). A summary of the responses and comparison between subgroups for all
questions on the survey can be found in Supplementary Tables 1, 2, and 3. Comparisons
between subgroups for all Likert-type questions are also shown in Table 2. Ordinal
regression for Likert-style responses of paired specialties including gender and years of
experience as covariates did not differ from the univariate results (Supplementary Table 4).
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Compared to PSC physicians, both RO and MO were significantly more likely to believe
that doctors know how to adequately care for the emotional and physical needs of patients
with a serious incurable illness. Both RO and MO were also less likely to believe that PSC
physicians were helpful at addressing these needs, though RO felt that PSC physicians was
more helpful than did MO. Palliative/supportive care physicians were more likely to believe
that patients with a serious incurable illness who are more aware of their life expectancy
tend to make better medical and personal decisions for the remainder of their life; however,
they were also least likely to believe that doctors consistently discuss prognosis with patients
with a serious incurable illness. Both RO and PSC physicians favored earlier initiation of
ACP than did MO. All participants felt that doctors are relatively unsuccessful at explaining/
clarifying advanced life-sustaining treatments, though PSC physicians to a greater extent
than RO or MO. As before, RO and MO were less likely to believe that PSC physician was
helpful in facilitating these discussions about advanced life-sustaining treatments. Palliative/
supportive care physician was also more likely to complete an advance directive for
themselves earlier in life and would favor less active/ life-prolonging types of treatments if
they themselves had an incurable illness with a poor prognosis.

Discussion

Author Manuscript

This study assessed differences in opinion between oncologists and PSC physicians
regarding ACP and end-of-life care as it relates to patients who they care for with advanced
cancer, as well as their personal views about their own future care. We found that although
there were many similarities between these subgroups, and that most responses were not
necessarily opposed to one another, there were generally more differences in philosophy
between PSC physicians and each group of oncologists than there were between radiation
and medical oncologists. In some ways, this may not be entirely surprising, given that
certain individuals choose their career path for a reason; however, this lack of shared beliefs
on a variety of issues may suggest an important reason why early PSC utilization has not
become the norm in many clinical practices despite high-level evidence supporting its
benefit to patients.
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The most notable finding from the study was that both the oncologists and PSC physicians
generally valued the others’ efforts less than they valued their own. For instance, PSC
physicians felt that doctors were less likely to discuss prognosis with their patients, were less
adept at ACP and managing the needs of dying patients, and favored earlier PSC
involvement and less aggressive treatments toward the end of life than did the oncologists.
Conversely, oncologists were less likely to recognize as many of these deficiencies and were
also less likely to believe that PSC physicians were helpful in addressing these issues. Our
finding that both groups undervalue the efforts of the other suggests (1) the inherent
difficulty in effectively managing this challenging patient population and (2) a lack of
understanding (among both groups) about how their colleagues are capable of helping
patients. For instance, medical and radiation oncologists who are never required to work
with PSC physicians during their training may not fully appreciate the breadth of
psychosocial and pharmacologic support that PSC physicians can provide. Similarly, PSC
physicians who are never required to rotate with an oncologist may not appreciate how
tumor-directed therapies like radiation and chemotherapy can be effectively used to palliate
Am J Hosp Palliat Care. Author manuscript; available in PMC 2019 October 01.
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symptoms in a variety of situations. Previous studies in the United States and Europe have
demonstrated that although most medical and radiation oncologists would like to learn more
about how to provide effective palliative care, the majority feel inadequately trained to do so.
22,28 While increased training does require more resources, there are data to support the
concept that this form of education in PSC increases the likelihood of ACP and better
hospice utilization.26 In our opinion, changing ACGME requirements to facilitate
multidisciplinary education would be a worthwhile undertaking, but for those who have
already completed their training, making a commitment to pursuing more open
communication at one’s own institution is likely to help bridge knowledge gaps and
facilitate greater trust and cohesion within the team.
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There are several limitations to this study. First and foremost, our low response rate is likely
to lead to some selection bias. It is unknown how much this bias impacted the responses,
though any bias introduced for this reason may be comparable for each subgroup since all
participants were likely to have some interest in the topic of the survey for them to respond.
Our findings may have also been somewhat skewed by the differential number of
participants in each subgroup. However, if anything, the lower power for the analyses
involving PSC physicians may mean that the extent of their differences with the oncologists
was actually underestimated. Understanding the views of surgical oncologists would have
also been valuable, though the initial survey did not target this population as much as the
others. Finally, an important issue which was not explored in this study is the impact of
patient misperceptions that equate palliative care with hospice care as a barrier to early PSC
referral.21,24,30 The rebranding of “palliative care” as “supportive care” in recent years may
help alleviate this problem; however, the way in which the referring physician describes the
PSC services to a patient may send the clearest message of the intention of the consultation.
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Conclusion
Significant differences in the perception of, and optimal logistics for, end-of-life care exist
between oncology subspecialists and PSC physicians. This suggests a need for improved
education and communication between subspecialists caring for patients with cancer nearing
the end of life in order to improve quality of life in this challenging patient population.
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Demographics of Participants.
Category

Characteristic

Radiation Oncology (n =
178), n (%)

Medical Oncology (n = 81), n
(%)

Palliative/Supportive Care (n =
51), n (%)

Experience

Resident/fellow

24 (13%)

13 (16%)

22 (43%)

1–10 years in practice

44 (25%)

19 (23%)

9 (18%)

11–20 years in practice

33 (19%)

17 (21%)

2 (4%)

21+ years in practice

70 (39%)

27 (33%)

14 (27%)

Unknown
Gender

Race

7 (4%)

5 (6%)

4 (8%)

Male

105 (59%)

47 (58%)

18 (35%)

Female

Author Manuscript

66 (37%)

29 (36%)

32 (63%)

Unknown

7 (4%)

5 (6%)

1 (2%)

Caucasian

137 (77%)

64 (79%)

34 (67%)

Asian

17 (10%)

5 (6%)

7 (14%)

Other
Unknown

3 (2%)

4 (4%)

2 (4%)

21 (12%)

8 (10%)

8 (16%)
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Summary of Likert-Type Scale Questions.
Radiation
Oncology, Mean
(SD); Median
(IQR)

Medical Oncology,
Mean (SD); Median
(IQR)

Palliative/Supportive
Care, Mean (SD);
Median (IQR)

How well do you think doctors know how to take care of the
emotional needs of patients with a serious incurable illness? (not at
all to extremely well)

2.4 (0.83); 3 (2–3)a

2.4 (0.72); 2 (2–3)b

1.7 (0.60); 2 (1–2)a,b

How well do you think doctors know how to take care of the
physical needs of patients with a serious incurable illness? (not at all
to extremely well)

3.5 (0.78); 4 (3–4)a,c

3.2 (0.81); 3 (3–4)b,c

2.5 (0.72); 2 (2–3)a,b

How helpful do you think palliative care doctors tend to be at
helping other physicians address the emotional and physical needs of
patients with a serious incurable illness? (not at all to extremely
helpful)

4.1 (0.94); 4 (4–5)a,c

3.8 (1.0); 4 (3–
4.5)b,c

4.5 (0.78); 5 (4–5)a,b

For patients with a serious incurable illness, do you believe that
patients who are more aware of their life expectancy tend to make
better medical decisions for the remainder of their life? (not at all to
extremely likely)

3.8 (0.8); 3 (3–4)a

3.8 (0.83); 4 (3–4)b

4.1 (0.65); 4 (4–5)a,b

For patients with a serious incurable illness, do you believe that
patients who are more aware of their life expectancy tend to make
better personal decisions for the remainder of their life? (not at all to
extremely likely)

3.9 (0.80); 4 (3–4)a

3.9 (0.85); 4 (3–4)b

4.3 (0.67); 4 (4–5)a,b

For patients with a serious incurable illness, do you believe that
patients who are more aware of their life expectancy tend to be more
emotionally prepared for dying? (not at all to extremely likely)

3.7 (0.87); 4 (3–4)

3.7 (0.92); 4 (3–4)b

4.0 (0.83); 4 (4–5)b

How successful do you think most doctors are at explaining/
clarifying advanced life-sustaining treatments with their patients?
(not at all to extremely successful)

1.7 (0.63); 2 (1–2)a

1.7 (0.80); 2 (1–2)b

1.3 (0.61); 1 (1–2)a,b

How much of the medical decisions you make about the end of your
life do you think you could make at a time when you are completely
healthy? (none to all)

2.9 (0.89); 3 (2–3)

3.0 (0.83); 3 (3–4)

2.8 (0.80); 3 (2–3)

Question
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Abbreviations: IQR, interquartile range; SD, standard deviation.
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a

Radiation oncology versus palliative/supportive care P value < .05.

b

Medical oncology versus palliative/supportive care P value < .05.

c

Radiation oncology versus medical oncology P value < .05.
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